| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 07/25/2002 | WO2000052153A3 Method to identify ligands for orphan receptors |
| 07/25/2002 | US20020100083 Propagating transgenic plants; obtain cells, transform with agrobacterium, recover transformed cells, generate embryos and propagate cells |
| 07/25/2002 | US20020100082 Method for determining content of heterologous individual |
| 07/25/2002 | US20020100081 Peroxisomal ascorbate peroxidase gene induced by high temperature stress and a transgeneic plant exibiting thermotolerance |
| 07/25/2002 | US20020100080 Insecticidal protein for use in biological pest control |
| 07/25/2002 | US20020100079 Maize metallothionein gene and promoter |
| 07/25/2002 | US20020100078 Method for enhancement of naturally occurring cytoplasmic male sterility and for restoration of male sterility and for restoration of male fertility and uses thereof in hybrid crop production |
| 07/25/2002 | US20020100077 Whisker-mediated transformation of plant cell aggregates and plant tissues and regeneration of plants thereof |
| 07/25/2002 | US20020100076 Generating transgenic plants; obtain cells, transform with vector containing preferential gene, detect signal from transformed cell, recover and propagate cell |
| 07/25/2002 | US20020100075 Genetically engineered plants for use in the generation of vitamin c |
| 07/25/2002 | US20020100074 Method for producing transformed plant having increased glutamic acid content |
| 07/25/2002 | US20020100073 Expressing somatotropin in plants; obtain cells, transform, propagate plant, recover fusion protein from seeds |
| 07/25/2002 | US20020100072 Nucleotide sequences coding polypeptide for use in expressing heterologous genes in plants |
| 07/25/2002 | US20020100071 Transgenic mouse with endogenous endoglin gene disruption |
| 07/25/2002 | US20020100070 Expression vectors coding polypeptide for use as tool in genetic engineering; for treatment of pain, tension and lung defects |
| 07/25/2002 | US20020100069 Treating heart defects; obtain tissue, incubate with modulator of transcription, evaluate tissue for defect |
| 07/25/2002 | US20020100068 Transgenic mouse for targeted recombination mediated by modified Cre-ER |
| 07/25/2002 | US20020100067 Isolated human G-protein coupled receptors, nucleic acid molecules encoding human GPCR proteins, and uses thereof |
| 07/25/2002 | US20020100066 Negative strand rna viral vector having autonomous replication capability |
| 07/25/2002 | US20020099511 Scanner and method for setting voltage value of photomultiplier |
| 07/25/2002 | US20020099202 Compoound for use in the sequencing of nucleic acids |
| 07/25/2002 | US20020099201 Oligonucleotides and method for characterizing and detecting genogroup II type small round structured virus |
| 07/25/2002 | US20020099199 Nucleotide sequences coding polypeptides for use in treatment of nervous system disorders; for use in learning enhancement |
| 07/25/2002 | US20020099198 Human endokine alpha |
| 07/25/2002 | US20020099196 Polypeptide for use in the treatment of cancer and hematopoietic defects |
| 07/25/2002 | US20020099194 Methods to overexpress a foreign gene in a cell or in an animal in vitro and in vivo |
| 07/25/2002 | US20020099193 Nucleotide sequences coding polypeptide for use in controlling gene expression in plants |
| 07/25/2002 | US20020099192 Hybrid oligonucleotide phosphorothioates |
| 07/25/2002 | US20020099191 EDG8 receptor, its preparation and use |
| 07/25/2002 | US20020099190 Nuclelotide sequences coding protein for use in the treatment and prevention of atherosclerosis, osteoporosis and nervous system disorders |
| 07/25/2002 | US20020099189 Novel nucleic acid and amino acid sequences |
| 07/25/2002 | US20020099181 Anti-fibroblast growth factor-8 monoclonal antibody |
| 07/25/2002 | US20020099178 Growth-associated protease inhibitor heavy chain precursor |
| 07/25/2002 | US20020099177 Human IRAK-2 |
| 07/25/2002 | US20020099173 Protein specific for cardiac and skeletal muscle |
| 07/25/2002 | US20020099169 Modulation of preferential transcription factor; obtain sample containing transcription factor, incubate with modulator, monitor transcriptional activity |
| 07/25/2002 | US20020099101 Use of flavonoid aldehydes as pesticides |
| 07/25/2002 | US20020099040 Sr-bi antagonists and use thereof as contraceptives and in the treatment of steroidal overproduction |
| 07/25/2002 | US20020099029 Induction of blood vessel formation through administration of polynucleotides encoding sphingosine kinases |
| 07/25/2002 | US20020099028 Genes and genetic elements associated with control of neoplastic transformation in mammalian cells |
| 07/25/2002 | US20020099027 Novel human thrombospondin repeat proteins and polynucleotides encoding the same |
| 07/25/2002 | US20020099026 Noninvasive; gene therapy; introducing electromagnetic field response elements into a gene promoter to serve as switches for regulating exogenously introduced genes; and applying electromagnetic field to induce gene expression. |
| 07/25/2002 | US20020099024 Including a nonnative amino acid sequence, and a chimeric adenovirus fiber protein lacking a native amino acid receptor-binding sequence. The chimeric protein trimerizes when produced in a mammalian cell. |
| 07/25/2002 | US20020099017 Gene designated EXP189 encoding an intercellular adhesion molecule; protein encoded by EXP189 used for diagnostic screening, for treating respiratory and inflammatory disorders, and for detecting genetic abnormalities |
| 07/25/2002 | US20020099016 Feed or food for vertebrates including humans for inhibiting diarrhea |
| 07/25/2002 | US20020099015 Gene expression control DNA element and associated protein |
| 07/25/2002 | US20020099014 Method for treatment of insulin resistance in obesity and diabetes |
| 07/25/2002 | US20020099012 Compositions and methods for the therapy and diagnosis of lung cancer |
| 07/25/2002 | US20020099010 Neurogenic compositions and methods |
| 07/25/2002 | US20020099009 Also diagnosing or detecting apoptosis as well as antibodies directed against the protein. |
| 07/25/2002 | US20020099006 Herpes viruses for immune modulation |
| 07/25/2002 | US20020099005 Mucin is present in a natural or modified form; includes delivery of DNA, RNA, PNA, polynucleotides and proteins into cells, tissues or organisms; gene therapy; customized therapeutics; vaccination; drug delivery |
| 07/25/2002 | US20020098996 Amylase variants |
| 07/25/2002 | US20020098582 Differentiated stem cells suitable for human therapy |
| 07/25/2002 | US20020098581 Carcinoma associated antigen (SK1) monoclonal antibodies against SK1, methods of producing these antibodies and use therefor |
| 07/25/2002 | US20020098580 MDM interacting protein and methods of use thereof |
| 07/25/2002 | US20020098577 Nucleotide sequences coding enzymatic polypeptide for use in treating cell proliferation and differentiation defects |
| 07/25/2002 | US20020098576 Recombinant sendai virus |
| 07/25/2002 | US20020098574 Microbes and methods for remediation |
| 07/25/2002 | US20020098573 Generating preferential vector nucleotide sequences; obtain nucleotide sequences, incubate with preferential exogenous nucleotide sequences, ligate, recover nucleotide sequences |
| 07/25/2002 | US20020098572 Conditional replication and expression system |
| 07/25/2002 | US20020098571 Plasmid for use as tool in genetic engineering |
| 07/25/2002 | US20020098570 Muskmelon (Cucumis melo) hydroperoxide lyase and uses thereof |
| 07/25/2002 | US20020098565 Polyhydroxyalkanoate synthase and gene encoding the same |
| 07/25/2002 | US20020098562 Enzymatic polypeptide for use in the generation of 2-pyrone-4,6-dicarboxylic acid |
| 07/25/2002 | US20020098561 Polypeptide for use in the treatment of thrombosis and arteriosclerosis |
| 07/25/2002 | US20020098560 Nuclelotide sequences coding enzyme inhibitor for use in the treatment of blood sisorders |
| 07/25/2002 | US20020098555 Microorganism; for use in the generation of arginine; for use in food processing; for use in activating liver health |
| 07/25/2002 | US20020098554 Nucleotide sequences coding polypeptide for use in human pharmacology, animal nutrition |
| 07/25/2002 | US20020098551 From a hybrid cell formed from the fusion of two or more cells, each of which cell is engineered to express one component of the multimeric protein, as well as a method for screening for successful fusion of the cells |
| 07/25/2002 | US20020098550 Nucleotide sequences coding membrane protein for use in treatment and prevention of endotoxin shock, viral disease, immflammation and tumors |
| 07/25/2002 | US20020098549 Mouse EDG1 |
| 07/25/2002 | US20020098547 Nucleotide sequences for use in controlling preferential gene expression and heterologous gene expression |
| 07/25/2002 | US20020098544 Polypeptide for use in screening bactericides |
| 07/25/2002 | US20020098542 Novel forms of T cell costimulatory molecules and uses therefor |
| 07/25/2002 | US20020098540 Novel polypeptides, and nucleic acids encoding the same |
| 07/25/2002 | US20020098539 Histamine receptor |
| 07/25/2002 | US20020098537 Having inhibitory activity on the protease activity of hepatocyte growth factor activator |
| 07/25/2002 | US20020098527 Gene recombinant antibody and antibody fragment thereof |
| 07/25/2002 | US20020098524 Screening peptide library for preferential proteins; obtain library, incubate with antitarget, separate unbound peptides, incubate unbound peptides with target binding protein, detect bound peptide complexes |
| 07/25/2002 | US20020098515 Antibody for use in the treatment of cancers and leukemias |
| 07/25/2002 | US20020098507 Nucleotide sequences coding polypeptide for use in human diagnostics and therapeutics; for use as biosensors |
| 07/25/2002 | US20020098506 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 07/25/2002 | US20020098505 Nucleotide sequences coding polypeptide for use in human diagnostics, therapeutics; for use as biosensors |
| 07/25/2002 | US20020098504 Fractionation of macro-molecules using asymmetric pulsed field electrophoresis |
| 07/25/2002 | US20020098503 Detection of preferential nucleotide sequences associated with biosynthetic pathways; obtain cell, transform, monitor expression of reporter molecule, generate library of expression products |
| 07/25/2002 | US20020098499 Method of sequencing |
| 07/25/2002 | US20020098494 Generating preferential nucleotides; obtain bacteria which generates nucleoside, culture, recover preferential nucleosides |
| 07/25/2002 | US20020098493 Drug-amino acids chimeric molecules |
| 07/25/2002 | US20020098491 Nuclelotide sequences coding preferential polypeptide; for use in human therapeutics, diagnostics and pharmacology |
| 07/25/2002 | US20020098490 Method for assaying DNA fragments in mixture |
| 07/25/2002 | US20020098488 Diagnosing mammary gland cancer; obtain tissue sample, extract nucleotide sequences, monitor sequence for mutation, presence of mutation indicates potential for development of mammary gland cancer |
| 07/25/2002 | US20020098486 Novel human transferase proteins and polynucleotides encoding the same |
| 07/25/2002 | US20020098477 Methods for screening nuclear transcription factors for the ability to modulate an estrogen response |
| 07/25/2002 | US20020098475 Bovine immunodeficiency virus (BIV) based vectors |
| 07/25/2002 | US20020098359 Method and apparatus for manufacture of magnetizable microparticles |
| 07/25/2002 | US20020098236 Transport vectors |
| 07/25/2002 | US20020098231 Antisense nucleotides; drug delivery; anticancer agents; gene expression inhibition |
| 07/25/2002 | US20020098223 Recombinant cells comprising retroviral vector |
| 07/25/2002 | US20020098202 Efficient hepatitis C virus replicon and its use in identifying antiviral compounds |